CP-316819 (Standard)

Overview

CP-316819 (GPi 819) Standard is the analytical standard of CP-316819 ( HY-108615 ). This product is intended for research and analytical applications. CP-316819 (GPi 819) is a blood-brain barrier permeable glycogen phosphorylase inhibitor. CP-316819 inhibits hepatic glycogenolysis, safely reduces blood glucose in type 2 diabetes, and rarely induces hypoglycemia. CP-316819 increases brain glycogen reserves, protects neurons, alleviates hypoglycemic brain injury, and inhibits excessive platelet activation, exerting both neuroprotective and vasculoprotective effects. CP-316819 can be used in research related to hypoglycemia, thrombosis, autoimmune inflammatory diseases, and type 2 diabetes.

Application

Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Metabolic or Endocrine Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Others | Products > Research Areas > Metabolic Disease | Products > Research Areas > Cardiovascular Disease | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > Phosphorylase | Products > Signaling Pathways > Reference Standards

Product Information

• Catalog No.: HY-108615R
• CAS No.: 186392-43-8
• Molecular Formula: C21H22ClN3O4
• Molecular Weight: 415.87
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source